Fertility Clinic EBITDA Valuation Multiples: 5x–9x Explained
What drives premium valuations for IVF practices and how private equity platforms like US Fertility and CCRM price acquisitions in today's consolidating market.
Fertility clinics trade at 5x–9x EBITDA in lower middle market M&A, reflecting strong demand from PE-backed platforms, limited supply of SART-accredited practices, and durable cash flow from self-pay IVF and egg freezing services. Single-physician practices command the low end; multi-RE clinics with diversified revenue attract aggressive bids near the top of the range.
Fertility Clinic EBITDA Multiple Ranges by Tier
| Business Tier | EBITDA Range | Multiple Range | Notes |
|---|---|---|---|
| Single-Physician, Basic IVF | $1.5M–$2M | 5x–6x | One RE, no associate, limited service lines, average or unpublished SART rates. High key-person risk reduces buyer confidence and pricing. |
| Established Two-Physician Practice | $2M–$3M | 6x–7x | Two board-certified REs, in-house IVF lab, SART membership, moderate self-pay mix. Suitable for regional network add-on acquisition. |
| Multi-Service Fertility Center | $3M–$4.5M | 7x–8x | Donor egg, PGT-A, egg freezing, and employer benefit contracts. Above-average SART success rates and clean regulatory history command this range. |
| Platform-Ready Regional Clinic | $4.5M+ | 8x–9x | Multiple REs, Progyny or WINFertility contracts, modern accredited lab, strong brand. Ideal platform for PE rollup commanding top-of-market pricing. |
What Drives Fertility Clinic Multiples
SART/CDC Success Rate Publication
High Positive impactClinics publishing above-average live birth rates attract more self-pay patients and signal quality to buyers, directly supporting premium multiples and reducing due diligence risk.
Single-Physician Dependency
High Negative impactA solo RE with no associate or succession plan introduces catastrophic key-person risk. Buyers apply 1x–2x multiple discount or require extended earnouts to mitigate.
Diversified Revenue Streams
Moderate Positive impactAdding egg freezing, PGT-A genetic testing, donor egg programs, and male fertility services expands revenue and reduces IVF cycle volume concentration risk.
Employer Fertility Benefit Contracts
High Positive impactLong-term agreements with Progyny or WINFertility provide contracted, recurring patient volume, improving revenue predictability and justifying higher valuation multiples.
IVF Laboratory Condition and Accreditation
Moderate Positive impactA fully accredited, modern IVF lab with current CLIA certification and documented QC protocols creates competitive barriers and avoids immediate post-close capital replacement costs.
Recent Market Trends
PE consolidation by platforms like US Fertility and Inception Fertility has compressed cap rates and elevated multiples since 2021. Expanding state insurance mandates are improving revenue visibility. Post-Dobbs legislative uncertainty around embryo personhood laws is introducing deal structure caution, particularly in Southern states, leading buyers to price regulatory risk into earnout provisions.
Sample Fertility Clinic Transactions
Two-RE suburban fertility center, SART member, egg freezing and PGT-A services, Progyny contract, clean regulatory history, Southeast market
$2.8M
EBITDA
7.2x
Multiple
$20.2M
Price
Solo-physician IVF clinic, average SART rates, no associate RE, basic service line, Midwest suburban market with strong local brand
$1.7M
EBITDA
5.5x
Multiple
$9.4M
Price
Three-RE regional fertility center, donor egg program, in-house andrology lab, above-average CDC success rates, employer benefit contracts, Mid-Atlantic
$4.2M
EBITDA
8.5x
Multiple
$35.7M
Price
EBITDA Valuation Estimator
Get your Fertility Clinic business value range instantly
Industry: Fertility Clinic · Multiples based on 6x–7x (Established Two-Physician Practice)
Powered by Deal Flow OS
dealflow-os.com · Free M&A tools for every stage of the deal
Frequently Asked Questions
Why are fertility clinic multiples higher than most medical practices?
Limited supply of SART-accredited clinics, strong self-pay pricing power, and aggressive PE platform demand create a seller-favorable market pushing multiples well above typical primary care or specialty practice norms.
Does SBA financing apply to fertility clinic acquisitions?
No. Fertility clinics are not SBA-eligible due to passive income characteristics of MSO structures and the complexity of corporate practice of medicine restrictions. Buyers use PE capital, seller notes, or conventional bank financing.
How does a single founding physician affect the sale price?
A solo RE with no associate triggers a 1x–2x multiple discount. Buyers require a signed long-term employment agreement, earnout tied to patient retention, or a seller-financed note to offset key-person departure risk.
What EBITDA normalization adjustments matter most in fertility clinic QoE reports?
Above-market physician compensation, one-time lab equipment purchases, personal expenses run through the practice, and embryo storage revenue timing are the most common add-backs reviewed in a fertility clinic quality of earnings analysis.
More Fertility Clinic Guides
Find Fertility Clinic businesses at the right price
DealFlow OS surfaces acquisition targets with seller signals and outreach angles. Free to join.
Start finding deals — freeNo credit card required